Franklin Street Advisors Inc Intra Cellular Therapies, Inc. Transaction History

Franklin Street Advisors Inc

  • $1.48 Billion
  • Q3 2024

A detailed history of Franklin Street Advisors Inc transactions in Intra Cellular Therapies, Inc. stock. As of the latest transaction made, Franklin Street Advisors Inc holds 10,753 shares of ITCI stock, worth $913,897. This represents 0.05% of its overall portfolio holdings.

Number of Shares
10,753
Previous 10,783 0.28%
Holding current value
$913,897
Previous $739,000 6.5%
% of portfolio
0.05%
Previous 0.05%

Shares

17 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Oct 09, 2024
SELL
$67.99 - $80.84 $2,039 - $2,425
-30 Reduced 0.28%
10,753 $787,000
Q2 2024

Jul 18, 2024
SELL
$64.76 - $79.84 $194,280 - $239,520
-3,000 Reduced 21.77%
10,783 $739,000
Q3 2023

Oct 10, 2023
SELL
$52.09 - $64.1 $3,906 - $4,807
-75 Reduced 0.54%
13,783 $718,000
Q1 2023

Apr 12, 2023
SELL
$43.8 - $56.99 $6,570 - $8,548
-150 Reduced 1.07%
13,858 $750,000
Q3 2022

Oct 11, 2022
SELL
$42.7 - $59.99 $106,750 - $149,975
-2,500 Reduced 15.14%
14,008 $652,000
Q2 2022

Jul 13, 2022
SELL
$43.0 - $65.64 $230,050 - $351,174
-5,350 Reduced 24.48%
16,508 $942,000
Q1 2022

Apr 18, 2022
SELL
$38.74 - $62.09 $544,297 - $872,364
-14,050 Reduced 39.13%
21,858 $1.34 Million
Q4 2021

Jan 26, 2022
BUY
$35.2 - $53.42 $111,584 - $169,341
3,170 Added 9.68%
35,908 $1.88 Million
Q3 2021

Oct 22, 2021
SELL
$28.72 - $42.49 $574,400 - $849,800
-20,000 Reduced 37.92%
32,738 $1.22 Million
Q2 2021

Aug 05, 2021
SELL
$29.3 - $44.5 $1,465 - $2,225
-50 Reduced 0.09%
52,738 $2.15 Million
Q3 2020

Oct 21, 2020
BUY
$17.61 - $31.86 $91,572 - $165,672
5,200 Added 10.93%
52,788 $1.36 Million
Q1 2020

Apr 16, 2020
BUY
$12.31 - $33.12 $61,550 - $165,600
5,000 Added 11.74%
47,588 $731,000
Q4 2019

Feb 14, 2020
SELL
$7.26 - $38.49 $72,600 - $384,900
-10,000 Reduced 19.02%
42,588 $1.46 Million
Q1 2019

May 14, 2019
BUY
$10.9 - $14.09 $5,755 - $7,439
528 Added 1.01%
52,588 $641,000
Q4 2018

Feb 14, 2019
SELL
$10.36 - $20.96 $20,720 - $41,920
-2,000 Reduced 3.7%
52,060 $593,000
Q4 2017

Jan 10, 2018
BUY
$14.27 - $16.79 $542,260 - $638,020
38,000 Added 236.61%
54,060 $783,000
Q3 2017

Oct 11, 2017
BUY
$10.77 - $22.1 $172,966 - $354,926
16,060
16,060 $253,000

Others Institutions Holding ITCI

# of Institutions
378
Shares Held
84.7M
Call Options Held
319K
Put Options Held
143K
View Full List

About Intra-Cellular Therapies, Inc.

ITCI Quotes by TradingView
  • Ticker ITCI
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Drug Manufacturers—Specialty & Generic
  • Shares Outstandng 94,401,696
  • Market Cap $8.02B
  • Description
  • Intra-Cellular Therapies, Inc., a biopharmaceutical company, develops novel drugs for the treatment of neuropsychiatric and neurologic diseases by targeting intracellular signaling mechanisms within the central nervous system in the United States. The company offers CAPLYTA for the treatment of schizophrenia in adults. It is also involved in dev...
More about ITCI
Track This Portfolio

Track Franklin Street Advisors Inc Portfolio

Follow Franklin Street Advisors Inc and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Franklin Street Advisors Inc , based on Form 13F filings with the SEC.

News

Stay updated on Franklin Street Advisors Inc with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email